Pepe price surged strongly this week as meme coin momentum returned, driven by speculation, whale activity, and renewed social trading interest. Pepe recorded strongPepe price surged strongly this week as meme coin momentum returned, driven by speculation, whale activity, and renewed social trading interest. Pepe recorded strong

Pepe Price Near $0.000007 as Weekly Gains Exceed 64%

2026/01/05 14:00
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Pepe price surged strongly this week as meme coin momentum returned, driven by speculation, whale activity, and renewed social trading interest.

Pepe recorded strong gains this week as meme coin momentum returned across crypto markets. Meanwhile, investor interest drove up sharply with the stock price soaring high. PEPE traded close to the $0.000007 as of January 4, 2026. Thus, the token received new interest among the retail traders and short-term speculators.

Pepe Rallies Strongly as Meme Coin Momentum Builds

The price of Pepe has gone up by over 14.48% within the last 24 hours. In the meantime, the weekly gains were around 64.73%, as per the CoinMarketCap data. Therefore, PEPE was one of the most effective performing meme tokens this week. It had a market capitalization that surpassed 2.9 billion, making it almost at position 34 in the world.

The highest point that the token had reached was an all-time high of $0.000028 on December 8, 2024. But the prices fell subsequently as the whole market had weakened. More recent speculative interest increased the prices yet again. Thus, dealers paid much attention to the resistance levels and short-term momentum indicators.

Related Reading: On-Chain Data Shows Huge PEPE Weekly Return

Trading volume was drastically higher and the price was also drastically higher as indicated in the market data. In the meantime, it was reported by blockchain trackers that the whale activity in recent sessions is high. Consequently, analysts advised of volatility in case of massive movements of holders. Nevertheless, in the short-term, momentum indicators were upward.

The recovery in Pepe was also associated with a larger recovery in meme coins. The other speculative tokens registered gains with improved risk appetite. As a result, there was a resurgence of the meme-based narratives in the social arenas. It was this renewed interest that favored short-run demand of PEPE tokens.

Speculation and Forecasts Fuel Renewed Market Interest

The latest surge came after a high-profiled assumption posted on Hyperliquid by one of the traders, James Wynn. He forecasted that PEPE would have a market capitalization of up to $69 billion by the end of 2026. The statement therefore spread rapidly on social networks and trading groups.

Immediately, the demand became visible, and speculative demand rose. Traders also re-entered the positions, anticipating upward momentum. Consequently, PEPE was liquid and the price movement was accelerated. This response indicated the role played by social narratives on meme tokens.

Pepe is a meme token that does not have basic utility or a dedicated team to develop it. Instead, it is based more on entertainment and community interaction. Hence, its pricing is largely subjective and speculative and market trend-based as opposed to fundamentals.

Regardless of such risks, the surge was a good indication of strong market participation in the short term. Retail traders were seen to be actively trading in centralized and decentralized exchanges. In the meantime, there was a significant increase in social engagement indicators of PEPE. This action helped in maintaining the interest in trading in the rally.

Overall, Pepe’s recent performance has shown rejuvenation in appetite for high-risk digital assets. Besides, speculative predictions intensified trading euphoria on the platforms. Memecoin cycles are prone to volatility as long as they happen. Thus, market participants remain attentive to changes in sentiment and whale behavior.

The post Pepe Price Near $0.000007 as Weekly Gains Exceed 64% appeared first on Live Bitcoin News.

Market Opportunity
Pepe Logo
Pepe Price(PEPE)
$0.000003356
$0.000003356$0.000003356
-0.35%
USD
Pepe (PEPE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09